CAK Determination on Provexa Pharma Kenya Limited v Shalina Healthcare Kenya Limited

dc.contributor.author	Competition Authority of Kenya
dc.date.accessioned	2024-03-24T18:48:27Z
dc.date.available	2024-03-24T18:48:27Z
dc.date.issued	2023-06-02
dc.identifier.uri	http://192.168.10.53/handle/123456789/250
dc.description.abstract	The Competition Authority of Kenya has approved the proposed acquisition of the entire issued share capital of Provexa Pharma Kenya Limited by Shalina Healthcare Kenya Limited unconditionally.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Competition Authority of Kenya	en_US
dc.subject	provexa pharma	en_US
dc.subject	shalina healthcare	en_US
dc.title	CAK Determination on Provexa Pharma Kenya Limited v Shalina Healthcare Kenya Limited	en_US